Chimerix (CMRX) Earnings Date, Estimates & Call Transcripts → Elon Musk’s Next Move Will Disrupt AI Forever (From InvestorPlace) (Ad) Free CMRX Stock Alerts $1.00 -0.05 (-4.76%) (As of 05/14/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 1EstimatedActual EPS (May. 1) -$0.25 Missed By -$0.04 Consensus EPS (May. 1) -$0.21 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get Chimerix Earnings AlertsEnter your email address below to receive the latest news and earnings results for CMRX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCMRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CMRX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceElon Musk’s Next Move Will Disrupt AI ForeverA revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here. Chimerix Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.21)($0.21)($0.21)Q2 20243($0.27)($0.23)($0.24)Q3 20243($0.28)($0.23)($0.25)Q4 20243($0.25)$0.05($0.14)FY 202411($1.01)($0.62)($0.85)Q1 20251($0.23)($0.23)($0.23)Q2 20251($0.24)($0.24)($0.24)Q3 20251($0.24)($0.24)($0.24)Q4 20251($0.23)($0.23)($0.23)FY 20254($0.94)($0.94)($0.94)CMRX Earnings Date and InformationChimerix last posted its earnings data on May 1st, 2024. The biopharmaceutical company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by $0.04. Chimerix has generated ($0.93) earnings per share over the last year (($0.93) diluted earnings per share). Earnings for Chimerix are expected to decrease in the coming year, from ($0.85) to ($1.03) per share. Chimerix has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More Chimerix Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024Estimated)------- 5/1/2024Q1 2024($0.21)($0.25)($0.04)($0.25)$1.31 million- 2/29/2024Q4 2023($0.23)($0.20)+$0.03($0.20)--11/2/2023Q3 2023($0.22)($0.27)($0.05)($0.27)$0.22 million$0.01 million8/3/2023Q2 2023($0.23)($0.21)+$0.02($0.21)$0.64 million$0.03 million5/4/2023Q1 2023($0.24)($0.24)-($0.24)$0.35 million$0.28 million3/2/2023Q4 2022($0.24)($0.24)-($0.24)$2.60 million$0.81 million Get the Latest News and Ratings for CMRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Chimerix and its competitors with MarketBeat's FREE daily newsletter. 11/3/2022Q3 2022$2.10$2.75+$0.65$2.75$205.30 million$32.56 million8/8/2022Q2 2022($0.24)($0.27)($0.03)($0.27)-$0.44 million 5/16/2022Q1 2022($0.35)($0.28)+$0.07($0.28)-$0.02 million 3/1/2022Q4 2021($0.11)($0.45)($0.34)($0.45)$45.06 million$0.05 million 11/4/2021Q3 2021($0.21)($0.21)-($0.21)$0.39 million$0.11 million 8/5/2021Q2 2021($0.19)($0.21)($0.02)($0.21)-$0.39 million Chimerix Earnings - Frequently Asked Questions When is Chimerix's earnings date? Chimerix has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on CMRX's earnings history. Did Chimerix beat their earnings estimates last quarter? In the previous quarter, Chimerix (NASDAQ:CMRX) missed the analysts' consensus estimate of ($0.21) by $0.04 with a reported earnings per share (EPS) of ($0.25). Learn more on analysts' earnings estimate vs. CMRX's actual earnings. How can I listen to Chimerix's earnings conference call? The conference call for Chimerix's latest earnings report can be listened to online. Listen to Conference Call How can I read Chimerix's conference call transcript? The conference call transcript for Chimerix's latest earnings report can be read online. Read Transcript How can I view Chimerix's earnings report? Chimerix's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Chimerix generate each year? Chimerix (NASDAQ:CMRX) has a recorded annual revenue of $41,000.00. How much profit does Chimerix generate each year? Chimerix (NASDAQ:CMRX) has a recorded net income of -$82.10 million. CMRX has generated -$0.93 earnings per share over the last four quarters. What is Chimerix's EPS forecast for next year? Chimerix's earnings are expected to decrease from ($0.85) per share to ($1.03) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Q32 Bio Earnings Results Barinthus Biotherapeutics Earnings Results Spero Therapeutics Earnings Results Oncolytics Biotech Earnings Results Vaccitech Earnings Results BioXcel Therapeutics Earnings Results Marinus Pharmaceuticals Earnings Results ProPhase Labs Earnings Results Milestone Pharmaceuticals Earnings Results Anixa Biosciences Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong Earnings This page (NASDAQ:CMRX) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chimerix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.